St. Renatus launches 1st nasal spray dental anesthetic: 5 things to know

St. Renatus has launched pre-order requests for its first product, a nasal-administered dental anesthetic called Kovanaze.

Here's what you need to know:

1. Kovanaze was approved by the FDA in June 2016.

2. Unlike standard dental anesthetic, which is administered through needle injection, Kovanaze is administered through a nasal spray.

3. Kovanaze is a topic, tooth nerve anesthetic containing tetracaineHCl (an ester local anesthetic) and oxymetazolineHCl (a vasoconstrictor).

4. The anesthetic is meant for restoratives procedures on Teeth 4 through 13 and A through J in adults and children who weigh more than 40 kilograms.

5. St. Renatus announced the launch of Kovanaze at the 2016 American Dental Association Meeting.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast